Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-09

Clinical Trial Update: SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

A randomized Phase 2/3 trial comparing selective internal radiation therapy (SIRT) followed by cisplatin-gemcitabine versus cisplatin-gemcitabine alone in unres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Gemcitabine (Gemcitabine)
  • SIR-Spheres Y-90 (yttrium-90 resin microspheres) (yttrium-90 resin microspheres)

Snippet

Sponsor: Sirtex Medical | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-05-09